Raptinal - HY-121320
Nur noch %1 verfügbar
Catalog #
HY-121320
Ab
103,00 €
Raptinal, a agent that directly activates caspase-3, initiates intrinsic pathway caspase-dependent apoptosis. Raptinal is able to rapidly induce cancer cell death by directly activating the effector caspase-3, bypassing the activation of initiator caspase-8 and caspase-9[1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-121320/Raptinal-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| CAS | 1176-09-6 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 386.44 |
| Solubility | DMSO : 20 mg/mL (ultrasonic;warming;heat to 60°C) |
| Clinical Information | No Development Reported |
| Target | Apoptosis;Caspase |
| Application: | Cancer-programmed cell death |
|---|